Apitox, Honeybee Venom Treatment for Osteoarthritis Pain and Inflammation

Completed · Phase 2

Conditions studied: Osteoarthritis of the Knee

In brief

The study will evaluate Apitox, pure honeybee venom as a treatment for pain and inflammation of osteoarthritis of the knee.

Key facts

Study ID

NCT00949754

Run by

Apimeds, Inc.

People needed

40

Starts

2009-10-01

Expected to finish

2010-04-01

Last updated by the study team

2010-05-05

Who can join

Age: 35 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• osteoarthritis of one or both knees
• on stable NSAID or none due to intolerance
• women either post menopausal or on stable birth control
• no clinically significant disease or or abnormal laboratory values
• signed informed consent, communicate effectively, understand and comply with all study requirements

You may not qualify if…

• serious or unstable medical or psychological condition
• known sensitivity to honeybee venom, histamine or lidocaine
• history of asthma
• any clinically significant ECG abnormalities
• any clinically significant laboratory values OOR
• history of drug or alcohol abuse
• history of joint injury and forms of inflammatory arthritis

Where it is running

• Radiant Research Inc. — Pinellas Park, Florida, United States
• Radiant Research - Chicago — Chicago, Illinois, United States
• Radiant Research - Columbus — Columbus, Ohio, United States
• Radiant Research - San Antonio — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.